Persistence of endometrial activity after radiation therapy for cervical carcinoma
Journal Article
·
· Obstet. Gynecol.; (United States)
OSTI ID:5529627
Radiation therapy is a proved treatment for cervical carcinoma; however, it destroys ovarian function and has been thought to ablate the endometrium. Estrogen replacement therapy is often prescribed for patients with cervical carcinoma after radiation therapy. A review of records of six teaching hospitals revealed 16 patients who had endometrial sampling for uterine bleeding after standard radiation therapy for cervical carcinoma. Fifteen patients underwent dilatation and curettage, and one patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy when a dilatation and curettage was unsuccessful. Six patients had fibrosis and inflammation of the endometrial cavity, seven had proliferative endometrium, one had cystic hyperplasia, one had atypical adenomatous hyperplasia, and one had adenocarcinoma. Although the number of patients who have an active endometrium after radiation therapy for cervical carcinoma is not known, this report demonstrates that proliferative endometrium may persist, and these patients may develop endometrial hyperplasia or adenocarcinoma. Studies have indicated that patients with normal endometrial glands have an increased risk of developing endometrial adenocarcinoma if they are treated with unopposed estrogen. Patients who have had radiation therapy for cervical carcinoma should be treated with estrogen and a progestational agent to avoid endometrial stimulation from unopposed estrogen therapy.
- OSTI ID:
- 5529627
- Journal Information:
- Obstet. Gynecol.; (United States), Journal Name: Obstet. Gynecol.; (United States) Vol. 6; ISSN OBGNA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Endometrial cancer following radiation therapy for cervical cancer
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals
Management of stage II endometrial adenocarcinoma
Journal Article
·
Fri May 01 00:00:00 EDT 1987
· Gynecol. Oncol.; (United States)
·
OSTI ID:6329222
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals
Journal Article
·
Mon Dec 14 23:00:00 EST 1981
· Am. J. Obstet. Gynecol.; (United States)
·
OSTI ID:5401432
Management of stage II endometrial adenocarcinoma
Journal Article
·
Mon Feb 29 23:00:00 EST 1988
· Obstet. Gynecol.; (United States)
·
OSTI ID:5290662
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BODY
CARCINOMAS
DISEASES
ESTRADIOL
ESTRANES
ESTROGENS
FEMALE GENITALS
HORMONES
HYDROXY COMPOUNDS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANS
PATIENTS
POST-IRRADIATION THERAPY
RADIOLOGY
RADIOTHERAPY
STEROID HORMONES
STEROIDS
THERAPY
UTERUS
62 RADIOLOGY AND NUCLEAR MEDICINE
BODY
CARCINOMAS
DISEASES
ESTRADIOL
ESTRANES
ESTROGENS
FEMALE GENITALS
HORMONES
HYDROXY COMPOUNDS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANS
PATIENTS
POST-IRRADIATION THERAPY
RADIOLOGY
RADIOTHERAPY
STEROID HORMONES
STEROIDS
THERAPY
UTERUS